Harmony Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Harmony Asset Management's PFE Position: Q2 2026 in Review
Harmony Asset Management reduced its Pfizer (PFE) stake by 9% in Q2 2026, selling an estimated $40.9K and leaving 15,783 shares worth $380K. The position accounts for 0.1% of the portfolio, ranked #147.
Harmony Asset Management first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $487K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Harmony Asset Management held 15,783 shares of Pfizer worth $380K as of Q2 2026.
- Harmony Asset Management sold 1,565 Pfizer shares in Q2 2026, an estimated $40.9K.
- Pfizer made up 0.1% of Harmony Asset Management's portfolio in Q2 2026, its #147 holding.
- Harmony Asset Management first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
- Harmony Asset Management's Pfizer position peaked at $487K in Q1 2026.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Harmony Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.